Register entryShortage reported
Milla Pharmaceuticals Inc.
- Registered sites
- 0
- Drug products
- 7
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Alert
Products in shortage
4| Drug | Presentation | Availability |
|---|---|---|
| Sodium Acetate Injection | Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) | Limited Availability |
| Sodium Acetate Injection | Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) | Available |
| Sodium Acetate Injection | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) | Available |
| Sodium Acetate Injection | Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) | Available |
Catalogue
Marketed products
7Showing 7 of 7.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Dihydroergotamine Mesylate | Dihydroergotamine Mesylate | INJECTION, SOLUTION | ANDA |
| Sodium Acetate | Sodium Acetate | INJECTION, SOLUTION, CONCENTRATE | ANDA |
| Sodium Acetate | Sodium Acetate | INJECTION, SOLUTION, CONCENTRATE | ANDA |
| Sodium Acetate | Sodium Acetate Injection, USP, 200 mEq/100 mL | INJECTION, SOLUTION, CONCENTRATE | ANDA |
| Sodium Acetate | Sodium Acetate Injection, USP, 400 mEq/100 mL | INJECTION, SOLUTION, CONCENTRATE | ANDA |
| Sodium Bicarbonate | Sodium Bicarbonate | INJECTION, SOLUTION | ANDA |
| Tromethamine | Tromethamine | INJECTION, SOLUTION | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.